Publications by authors named "P Rey del Corral"
Purpose Of Review: This article explores the cardiovascular effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes mellitus (T2DM), with a particular focus on their impact on lipid profiles. As evidence grows of the cardiovascular benefits of SGLT2i beyond glucose control, it is essential to better understand their effects on lipoproteins and their impact on cardiovascular disease.
Recent Findings: SGLT2i have shown significant cardiovascular benefits in patients with type 2 diabetes mellitus, beyond their role in lowering blood glucose.
Lipoprotein (a) [Lp(a)] is a lipoprotein with multiple deleterious characteristics and is a recognized cardiovascular (CV) risk factor. The pro-atherogenic, pro-thrombotic, and pro-inflammatory features of Lp(a) are associated not only with atherosclerotic vascular disease but also with aortic valve calcification and all-cause mortality. One of the most interesting aspects of Lp(a) is that its level is determined by genetics in more than 90% of cases, with lifestyle habits having very little influence.
View Article and Find Full Text PDFArticle Synopsis
- The document provides guidelines for managing patients with type 2 diabetes (T2D) after they are discharged from the hospital following a heart event, emphasizing the connection between diabetes and increased heart risks.
- It recommends strict management of cholesterol levels using powerful statins and other medications, along with optimal blood pressure treatment to prevent future issues like heart attacks or strokes.
- Education on nutrition, lifestyle changes, and regular monitoring of treatments are crucial for controlling T2D and minimizing cardiovascular risks, especially focusing on weight management.
[Design and rationale: Observational Study of the Argentine Group for the Study of Lipoprotein (a)].
Hipertens Riesgo Vasc
October 2024
Introduction: Elevated levels of Lipoprotein(a) [Lp(a)] have been linked to increased cardiovascular risk globally. However, comprehensive studies on Lp(a) levels and their impact on cardiovascular health in Argentina are lacking. The Argentine Group for the Study of Lipoprotein (a) [GAELp(a)] aims to address this gap through an observational study designed to evaluate the prevalence and consequences of elevated Lp(a) levels in the Argentine population.
View Article and Find Full Text PDFObjectives: In this study, the effects of short-duration high-intensity exercise and long-duration exercise on high-sensitivity cardiac troponin T (hs-cTnT) levels were compared.
Methods: Twelve male amateur cyclists performed 1- and 6-h cycling trials. In both exercise trials, hs-cTnT was assessed at rest, immediately postexercise and at 1, 3, 6, 12, and 24 h postexercise.